MALAYSIA: Malaysia-China Joint Evaluation Pilot Programmed (Phase 2), 1st July to 30th September 2026 – June/July 2026

• 2026-07-27 03:03:43

The Medical Device Authority (MDA) of Malaysia has announced a commencement of the second phase of The Malaysia–China Joint Evaluation Pilot Programme upon successfulness of Malaysia–China Medical Device Regulatory Reliance Programme (Pilot Phase I) in 2025. Pilot phase 2 will run from 1 July 2026 to 30 September. The programme enables the MDA and China's National Medical Products Administration (NMPA) to conduct a collaborative joint evaluation of eligible medical device registration applications under the GHWP Common Evaluation Reliance Practice (CERP).

了解更多